Cerity Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $100M | Sell |
199,575
-911
| -0.5% | -$437K | 0.12% | 154 |
|
|
2026
Q1 | $98.5M | Sell |
200,486
-210,556
| -51% | -$114M | 0.14% | 140 |
|
|
2025
Q4 | $238M | Buy |
411,042
+201,956
| +97% | +$114M | 0.35% | 53 |
|
|
2025
Q3 | $101M | Sell |
209,086
-15,549
| -7% | -$7.24M | 0.16% | 124 |
|
|
2025
Q2 | $91.1M | Sell |
224,635
-2,142
| -0.9% | -$896K | 0.16% | 133 |
|
|
2025
Q1 | $113M | Buy |
226,777
+65,262
| +40% | +$35.3M | 0.23% | 93 |
|
|
2024
Q4 | $88.9M | Sell |
161,515
-19,909
| -11% | -$10.9M | 0.19% | 106 |
|
|
2024
Q3 | $112M | Buy |
181,424
+30,687
| +20% | +$18.2M | 0.25% | 84 |
|
|
2024
Q2 | $83.4M | Sell |
150,737
-29,046
| -16% | -$16.6M | 0.22% | 100 |
|
|
2024
Q1 | $104M | Buy |
179,783
+34,815
| +24% | +$19.5M | 0.28% | 74 |
|
|
2023
Q4 | $76.9M | Buy |
144,968
+37,970
| +35% | +$18.4M | 0.25% | 92 |
|
|
2023
Q3 | $54.2M | Sell |
106,998
-103,914
| -49% | -$55.4M | 0.26% | 99 |
|
|
2023
Q2 | $110M | Buy |
210,912
+16,333
| +8% | +$8.81M | 0.43% | 53 |
|
|
2023
Q1 | $113M | Buy |
194,579
+37
| +0% | +$20.9K | 0.27% | 55 |
|
|
2022
Q4 | $108M | Buy |
194,542
+104,622
| +116% | +$55.4M | 0.69% | 24 |
|
|
2022
Q3 | $45.6M | Sell |
89,920
-723
| -0.8% | -$405K | 0.55% | 32 |
|
|
2022
Q2 | $49.2M | Sell |
90,643
-12,340
| -12% | -$6.79M | 0.54% | 32 |
|
|
2022
Q1 | $60.1M | Buy |
102,983
+3,170
| +3% | +$1.82M | 0.93% | 15 |
|
|
2021
Q4 | $65.7M | Buy |
99,813
+6,447
| +7% | +$4.03M | 1% | 16 |
|
|
2021
Q3 | $53.3M | Buy |
93,366
+797
| +0.9% | +$437K | 1.17% | 12 |
|
|
2021
Q2 | $46.7M | Buy |
92,569
+1,822
| +2% | +$860K | 1.02% | 16 |
|
|
2021
Q1 | $41.4M | Buy |
90,747
+20,728
| +30% | +$9.89M | 0.98% | 17 |
|
|
2020
Q4 | $32.6M | Sell |
70,019
-289
| -0.4% | -$136K | 1.05% | 14 |
|
|
2020
Q3 | $31M | Buy |
70,308
+48,217
| +218% | +$19.9M | 1.28% | 12 |
|
|
2020
Q2 | $8M | Buy |
22,091
+8,234
| +59% | +$2.76M | 0.44% | 44 |
|
|
2020
Q1 | $3.93M | Buy |
13,857
+1,060
| +8% | +$334K | 0.25% | 79 |
|
|
2019
Q4 | $4.16M | Sell |
12,797
-9,890
| -44% | -$3M | 0.21% | 90 |
|
|
2019
Q3 | $6.61M | Buy |
22,687
+4,536
| +25% | +$1.3M | 0.39% | 60 |
|
|
2019
Q2 | $5.33M | Sell |
18,151
-12,939
| -42% | -$3.56M | 0.34% | 74 |
|
|
2019
Q1 | $8.51M | Sell |
31,090
-12,390
| -28% | -$3.08M | 0.57% | 35 |
|
|
2018
Q4 | $9.73M | Buy |
43,480
+4,495
| +12% | +$1.05M | 0.65% | 28 |
|
|
2018
Q3 | $9.52M | Buy |
38,985
+1,568
| +4% | +$361K | 0.66% | 29 |
|
|
2018
Q2 | $7.75M | Sell |
37,417
-1,338
| -3% | -$284K | 0.57% | 36 |
|
|
2018
Q1 | $8M | Sell |
38,755
-2,742
| -7% | -$576K | 0.61% | 36 |
|
|
2017
Q4 | $7.88M | Sell |
41,497
-921
| -2% | -$176K | 0.53% | 34 |
|
|
2017
Q3 | $8.03M | Sell |
42,418
-27,471
| -39% | -$4.98M | 0.57% | 35 |
|
|
2017
Q2 | $9.46M | Buy |
69,889
+30,672
| +78% | +$5.15M | 0.79% | 22 |
|
|
2017
Q1 | $6.02M | Buy |
39,217
+25,801
| +192% | +$3.94M | 0.5% | 31 |
|
|
2016
Q4 | $1.89M | Buy |
+13,416
| New | +$1.98M | 2.61% | 14 |
|
Other funds holding TMO
VCM
VPM
Cerity Partners's TMO Position: Q2 2026 in Review
Cerity Partners reduced its Thermo Fisher Scientific (TMO) stake by 0.45% in Q2 2026, selling an estimated $437K and leaving 199,575 shares worth $100M. The position accounts for 0.12% of the portfolio, ranked #154.
Cerity Partners first reported a position in TMO in Q4 2016 and has held it in 39 quarters since. The position peaked at $238M in Q4 2025. 2,375 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Cerity Partners held 199,575 shares of Thermo Fisher Scientific worth $100M as of Q2 2026.
- Cerity Partners sold 911 Thermo Fisher Scientific shares in Q2 2026, an estimated $437K.
- Thermo Fisher Scientific made up 0.12% of Cerity Partners's portfolio in Q2 2026, its #154 holding.
- Cerity Partners first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 39 quarters since.
- Cerity Partners's Thermo Fisher Scientific position peaked at $238M in Q4 2025.
- 2,375 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.